Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB25FEFTU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $74,857
Award facts
- Contract value 100% obligated
- $74,856.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $74,856.82 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300mg dose in 2-pen/mL formulations. This firm fixed price, non-set-aside contract was awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor contract valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, provides a comprehensive portfolio of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The SPE2DX IDC serves as a global pharmaceutical support vehicle enabling the company to supply specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. This delivery order for Cosentyx, a biologic immunosuppressant used to treat autoimmune conditions, represents a routine fulfillment under the company's established federal contract vehicle and reflects AmerisourceBergen's capacity to meet competitive federal procurement requirements for specialized pharmaceutical products.
Quick answers
Who was awarded contract SPE2DB25FEFTU?
SPE2DB25FEFTU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 4, 2025.
How much is contract SPE2DB25FEFTU worth?
The government has obligated $74,857 on SPE2DB25FEFTU.
Is contract SPE2DB25FEFTU an order under another contract?
Yes. SPE2DB25FEFTU is a delivery order under SPE2DB24D2205, an indefinite delivery contract.
Was contract SPE2DB25FEFTU competed?
The extent of competition for SPE2DB25FEFTU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award